<?xml version="1.0" encoding="UTF-8"?>
<ref id="B133">
 <label>133</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lutsenko</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hagenow</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Affini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Reiner</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Stark</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Rasagiline derivatives combined with histamine H3 receptor properties</article-title>
  <source>
   <italic toggle="yes">Bioorganic &amp; Medicinal Chemistry Letters</italic>
  </source>
  <year>2019</year>
  <volume>29</volume>
  <issue>19</issue>
  <fpage>p. 126612</fpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2019.08.016</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85070553648</pub-id>
  <?supplied-pmid 31421966?>
  <pub-id pub-id-type="pmid">31421966</pub-id>
 </element-citation>
</ref>
